No abstract

The in vitro antiproliferative activity of the title compound on five tumor cell lines shows preference for the colon-rectal tumor HCT116, IC(50) = 13.98 μM, followed by breast MCF7 (19.58 μM) and ovarian A2780 (23.38 μM) cell lines; human glioblastoma U-87 and lung carcinoma A549 are less sensitive. A commercial curcumin reagent, also containing demethoxy and bis-demethoxy curcumin, was used to synthesize the title compound, and so (p-cymene)Ru(demethoxy-curcuminato)chloro was also isolated and chemically characterized. The crystal structure of the title compound shows (1) the chlorine atom linking two neighboring complexes through H-bonds with two O(hydroxyl), forming an infinite two-step network; (2) significant twist in the curcuminato, 20° between the planes of the two phenyl rings. This was also seen in the docking of the Ru-complex onto a rich guanine B-DNA decamer, where a Ru-N7(guanine) interaction is detected. This Ru-N7(guanine) interaction is also seen with ESI-MS on a Ru-complex-guanosine derivative.

A series of novel ruthenium(II) arene RAPTA type derivatives (arene = cymene, hexamethylbenzene) containing curcumin-based ligands (curcH = curcumin, bdcurcH = bisdemethoxycurcumin) and PTA (1,3,5-triaza-7-phosphaadamantane) have been synthesized and fully characterized. The solid-state structures of [Ru(cym)(curc)(PTA)][SO3CF3], [Ru(hmb)(curc)(PTA)][SO3CF3], and [Ru(hmb)(bdcurc)(PTA)][SO3CF3] have been determined by single-crystal X-ray diffraction. The antitumor activity of the complexes has been evaluated in vitro against human ovarian carcinoma cells (A2780 and A2780cisR), as well as against nontumorous human embryonic kidney (HEK293) cells. The correlation of the cytotoxicity upon switching the curcumin-based ligands, i.e. curcumin vs bisdemethoxycurcumin, is not straightforward. In contrast, the PTA ligand greatly enhances the activity and selectivity of ruthenium compounds in comparison to previously reported compounds

The burgeoning field of metal − organic frameworks or porous coordination polymers has received increasing interest in recent years. In the last decade these microporous materials have found several applications including storage and separation of gases, sensors, catalysis and functional materials. In order to better design new metal − organic frameworks and porous coordination polymers with specific functionalities a fundamental issue is to achieve a basic understanding of the relationship between molecular parameters and structures, preferred adsorption sites and properties by using using modern theoretical methods. The focus of this mini-review is a description of the potential and emerging applications of metal − organic frameworks.

No abstract

No abstract

No abstract

The complexes [Mo(O)2(QR)2] [R = cyclohexyl (1), ethylcyclopentyl (2), hexyl (3), and neopentyl (4)] have been obtained in good yields by treatment of [Mo(O)2(acac)2] with 2 equivalents of acylpyrazolone compounds HQR [HQR = 3‐methyl‐1‐phenyl‐4‐alkylcarbonyl‐5‐pyrazolone; R = cyclohexyl (HQCy), ethylcyclopentyl (HQEtCp), hexyl (HQHe), neopentyl (HQnPe)]. They were isolated as yellow crystalline solids and characterized spectroscopically [IR, 1H and 13C(1H) NMR] and structurally (X‐ray for 2 and 3). The deoxygenation of selected epoxide substrates to alkenes by employing compounds 1 and 3 as catalysts and PPh3 as the oxygen acceptor showed good activities in toluene. The use of the ionic liquid [C4mim]PF6 as solvent gave lower yields, but the resulting catalytic system could be conveniently recycled. The [Mo(O)2(QR)2] derivatives 1 and 3 were also found to be moderately active catalysts for the deoxydehydration of vicinal diols.